Temiz, S. A., & Daye, M. (2022). Dapsone for the treatment of acne vulgaris: Do the risks outweigh the benefits? Cutaneous & Ocular Toxicology, 41(1), 60. https://doi.org/10.1080/15569527.2021.2024565
Chicago Style (17th ed.) CitationTemiz, Selami Aykut, and Munise Daye. "Dapsone for the Treatment of Acne Vulgaris: Do the Risks Outweigh the Benefits?" Cutaneous & Ocular Toxicology 41, no. 1 (2022): 60. https://doi.org/10.1080/15569527.2021.2024565.
MLA (9th ed.) CitationTemiz, Selami Aykut, and Munise Daye. "Dapsone for the Treatment of Acne Vulgaris: Do the Risks Outweigh the Benefits?" Cutaneous & Ocular Toxicology, vol. 41, no. 1, 2022, p. 60, https://doi.org/10.1080/15569527.2021.2024565.
Warning: These citations may not always be 100% accurate.